WGS250117P100000
- 10.50
- 0.000.00%
GeneDx Holdings Newsroom
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating
GeneDx Holdings Is Maintained at Buy by TD Cowen
GeneDx Hldgs Analyst Ratings
TD Cowen Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $118
GeneDx Holdings Is Maintained at Buy by Craig-Hallum
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $95
GeneDx Hldgs Analyst Ratings
Wells Fargo Maintains GeneDx Holdings(WGS.US) With Hold Rating, Raises Target Price to $75
TD Cowen Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $75
BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $95
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $70
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $70
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Announces Target Price $70
GeneDx Hldgs Analyst Ratings
Goldman Sachs Maintains Neutral on GeneDx Hldgs, Raises Price Target to $54
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating
Craig-Hallum Issues a Buy Rating on GeneDx Holdings (WGS)
GeneDx Holdings Price Target Raised to $45.00/Share From $35.00 by BTIG
GeneDx Hldgs Analyst Ratings